C H Weaver
Impact in
- Hematology top 0.5%
- Hematopoietic Stem Cell Transplantation
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
- Genetics top 5%
- Mesenchymal stem cell research
Papers in
-
- Hematopoietic Stem Cell Transplantation 4
- Multiple Myeloma Research and Treatments 2
- Oncology 4
- Neutropenia and Cancer Infections 2
- Co-authors
- Jack W. Singer (7 shared papers)Scott D. Rowley (4 shared papers)CD Buckner (4 shared papers)Rainer Storb (4 shared papers)W. H. West (1 shared paper)Lee S. Schwartzberg (1 shared paper)Peter Palmer (1 shared paper)Cathy Allen (1 shared paper)
- Journals
- Blood (4 papers)Journal of Clinical Oncology (2 papers)PubMed (2 papers)
- Partner nations
- United States
In The Last Decade
C H Weaver
8 papers receiving 1.3k citations
C H Weaver's Hit Papers
Peers
Comparison fields: 5 of 47
- Hematology 996
- Genetics 190
- Oncology 404
- Transplantation 35
- Immunology 278
Countries citing papers authored by C H Weaver
This map shows the geographic impact of C H Weaver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C H Weaver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C H Weaver more than expected).
Fields of papers citing papers by C H Weaver
This network shows the impact of papers produced by C H Weaver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C H Weaver. The network helps show where C H Weaver may publish in the future.
Co-authors
The 25 scholars most cited alongside C H Weaver, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy Hit paper breakdown → | 1995 | 498 |
| 2 | 1995 | 465 | |
| 3 | 1993 | 146 | |
| 4 | 1996 | 84 | |
| 5 | 1994 | 52 | |
| 6 | Phase I study of high-dose busulfan, melphalan and thiotepa with autologous stem cell support in patients with refractory malignancies. | 1994 | 39 |
| 7 | High-dose busulfan, melphalan, and thiotepa followed by autologous peripheral blood stem cell transplantation in patients with aggressive lymphoma or relapsed Hodgkin's disease. | 1997 | 22 |
| 8 | 1993 | 9 |
About C H Weaver
C H Weaver is a scholar working on Hematology, Oncology, Genetics, Emergency Medicine and Infectious Diseases, having authored 8 papers that have together received 1.3k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (4 papers), Mesenchymal stem cell research (2 papers), Multiple Myeloma Research and Treatments (2 papers), Neutropenia and Cancer Infections (2 papers), Hematological disorders and diagnostics (2 papers), Acute Lymphoblastic Leukemia research (1 paper), Antifungal resistance and susceptibility (1 paper) and Lymphoma Diagnosis and Treatment (1 paper). The work is most often cited by research in Hematology (996 citations), Genetics (190 citations), Oncology (404 citations), Transplantation (35 citations) and Immunology (278 citations). C H Weaver has collaborated with scholars based in United States. Frequent co-authors include Jack W. Singer, Scott D. Rowley, CD Buckner, Rainer Storb, W. H. West, Lee S. Schwartzberg, Peter Palmer, Cathy Allen, B Hazelton and Robert Birch. Their work appears in journals such as Blood, Journal of Clinical Oncology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.